Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
205.4 SEK | +0.39% | +0.10% | +61.29% |
18/06 | Calliditas Therapeutics Gets US Patent for Cancer Treatment Candidate | MT |
18/06 | Calliditas Therapeutics Secures US Patent for Cancer Treatment Inhibitor | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+61.29% | 105.31Cr | |
+15.06% | 7.65TCr | |
+13.50% | 898.66Cr | |
-22.91% | 438.8Cr | |
+33.84% | 418.92Cr | |
+10.76% | 412.76Cr | |
+8.44% | 216.02Cr | |
-30.28% | 207.24Cr | |
+8.58% | 196.45Cr | |
-44.99% | 171.85Cr |
- Stock Market
- Equities
- CALTX Stock
- News Calliditas Therapeutics AB
- Stifel Downgrades Calliditas Therapeutics to Hold From Buy, Cuts Price Target to $40 From $55